Infinity Mining Limited · ASX:IMI

Infinity Mining — IM Medical — Investor Presentation (November 2006)

25 slides from Infinity Mining's investor presentation, Nov 29, 2006

  1. Slide 1: Investor Update

    (ASX Code—IMI) Investor Update 29/11/06

  2. Slide 2: The value of IM Medical

    The value of IM Medical Pulse Wave Analysis Pioneers We are the future of non-invasive diagnostics for many modalities

  3. Slide 3: What we have done

    What we have done…. „ Started with executive testing „ Moved to general population testing „ Created a market inside General Practices „ Leveraged current and emerging MBS item numbers „ Developed portable devices which run a configurable process „ 45 practices in Victoria now, another 15 being inst

  4. Slide 4: Intelliheart Devices

    Intelliheart® Devices Tonometer Phase 2 Phase 3

  5. Slide 5: Next Phase Device

    Next Phase Device „ Phase IV Device „ Uses radial +/- carotid artery „ Portable „ Cost $25,000 „ Needs new software development

  6. Slide 6: Future Device

    Future Device „ Phase 5 device „ Pharmacy potential „ Follow-up in home, casualty etc. „ Cost $10,000 (+laptop & phone internet connection)

  7. Slide 7: Benefits

    Benefits 1. Recurrent income 2. Non-invasive test—no needles Detects vascular changes consistent 3. Internet-based reporting & with 20% blockage of billing systems coronary arteries 4. Preventative medicine (takes 20 minutes)

  8. Slide 8: Cardiovascular Disease

    Cardiovascular Disease „ CVD is biggest killer in the western world „ Approx 40% of western world dies from CVD „ 25% of Australian adults have some sort of CV condition and „ 90% have at least one major risk factor „ Health is 10% of GDP in 2005

  9. Slide 9: Obesity

    Obesity OBESITY could knock economic output as severely as malnutrition, which shaves as much as 3 per cent off production in the poorest countries, a World Bank specialist said Nov.06 The World Health Organisation estimates obesity has tripled in the past two decades 1 in 10 children & 1 in 5 adult

  10. Slide 10: Blockage levels 20%, 50%, 70%

    20% Blockage 50% 70% Blockage Blockage

  11. Slide 11: Stress / Relaxation Ratio

    Stress \ Relaxation Ratio 3.7 Cardise Efficiency 39 %o Central Vessel Elasticity Cardiac Suxygenation (fitness) 151 ms 139 % Body Mass Index (BMI) Blood Pressure 34.8 124/91 mmHg Overall Vessel Stiffness 14% Waist \ Hip Ratio 0.98 Peripheral Vessel Stifmess 4 mmHg

  12. Slide 12: What we do

    What we do.... IM Medical Executive Screen Allied Health Care GP Care Plan PWA

  13. Slide 13: Sales Offer

    Sales Offer Variable Offers Associate Partner Sell device Free device Charge for Charge per service maintenance

  14. Slide 14: Selling options

    Selling options Sell machine $38,000 Option 1 Support & Maintenance Associate Practices Agreement Consulting Service Other ad-hoc services per request Sell a Service & Reports Option 2 Executive test $300 Partners Wellness test $200 Care Plan $80 PWA $50

  15. Slide 15: Option 2

    Option 2 What can we earn— per device per week?

  16. Slide 16: IM Care Plan Revenue Scenario

    IM Care Plan Revenue Scenario @$80/test net to IMI 45 devices 60 devices 120 devices 10 tests/ day $36,000/day $48,000/day $96,000/day Annualized (250days) $9,000,000m $12,000,000m $24,000,000m

  17. Slide 17: PWA Test Revenue Scenario

    PWA Test Revenue Scenario @$50/test net to IMI 1 device 25 devices 100 devices 250 devices 10 tests/day $500/ day $12,500/day $50,000/day $125,000/day Annual $125,000 $3,125,000m $12,500,000m $31,250,000m (250 days)

  18. Slide 18: Our Revenue Model

    Our Revenue Model 250 200 Consult Fee $ 150 Cumulative $ 100 4 visits over 50 18/12 0 1st Visit +6/12 +12/12 +18/12

  19. Slide 19: Our Operating Expense Model

    Our Operating Expense Model Expenses 450,000 400,000 350,000 300,000 Fixed Quarterly 250,000 Costs $ 200,000 Variable 150,000 Quarterly Costs $ 100,000 Total $ 50,000 0 Q3 Q4 Q1 Q2 2006 2006 2007 2007

  20. Slide 20: Activity Increasing - Targets Exceeded

    Activity Increasing-Targets Exceeded 1800 1600 1400 No of 1200 Tests/ 1000 Month 800 600 Target 400 Actuals 200 0 Fe Ap Ju Au Oc br n ua ril e gu s t to be ry r

  21. Slide 21: The Board

    The Board Executive Chairman: „ Dr L Williams Non-Executive Directors: „ Mr. A Blood „ Mr. P Wilson AM

  22. Slide 22: Rollout Strategy

    Rollout Strategy „ Roll-out to 60 machines by end of December 2006 „ Portable strategy to continue „ Rural GP Vic started „ Interstate rollout expected to start Q1 2007 „ Target: July 2007 90 machines placed December 2007 120 placed

  23. Slide 23: Our Opportunity

    Our Opportunity…. „ for GP offices „ 120 devices in each of Vic & NSW, „ 50 devices Qld & WA „ 30 devices Tas & SA „ Aboriginal Health Screening (10 portables per State) „ Broader tests „ Full vascular diagnostic „ Pulmonary diagnostic „ PWA tests for other modalities

  24. Slide 24: What we have learnt

    What we have learnt… „ How to develop a close relationship with doctors & staff „ How to leverage from the practice manager „ How to have a live terminal in doctors offices with our own operator „ How to introduce new technology products to doctors & staff „ How to expand our model

  25. Slide 25: Summary

    Summary We are: „ Using our core technology to develop new services in new areas „ Developing a strategic place in the industry „ We offer good potential earnings growth „ Meeting targets

IM Medical — Investor Presentation (November 2006) on 6ix